224 related articles for article (PubMed ID: 15712148)
21. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
[TBL] [Abstract][Full Text] [Related]
23. Is bone marrow biopsy a prognostic parameter in B-CLL?
Raphael M; Chastang C; Binet JL
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):377-8. PubMed ID: 3222148
[TBL] [Abstract][Full Text] [Related]
24. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
Urasiński I; Zdziarska B; Krygier-Stojałowska A
Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
MacCallum S; Groves M; Brass D; Cunningham J; Sales M; Gelly K; Tauro S
J Clin Pathol; 2009 May; 62(5):468-70. PubMed ID: 19398596
[TBL] [Abstract][Full Text] [Related]
26. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment.
Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M
Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow biopsy in chronic lymphocytic leukaemia: a study of 208 cases.
Montserrat E; Rozman C
Haematologia (Budap); 1983; 16(1-4):73-9. PubMed ID: 6679490
[TBL] [Abstract][Full Text] [Related]
28. [Structural and functional changes of bone marrow stroma in chronic lymphocytic leukemia].
Shatseva TA; Rugal' VI; Novozhilova AP; Kiseleva MV; Zhiburt EB
Vopr Onkol; 1999; 45(3):249-53. PubMed ID: 10443225
[TBL] [Abstract][Full Text] [Related]
29. Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Eichhorst BF; Busch R; Schweighofer C; Wendtner CM; Emmerich B; Hallek M;
Br J Haematol; 2007 Jan; 136(1):63-72. PubMed ID: 17083342
[TBL] [Abstract][Full Text] [Related]
30. An unusual case of chronic lymphocytic leukemia.
Hollander SL
J Med; 1991; 22(4-5):289-97. PubMed ID: 1787387
[TBL] [Abstract][Full Text] [Related]
31. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
32. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
33. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
[TBL] [Abstract][Full Text] [Related]
34. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
Cheson BD
Semin Hematol; 1998 Jul; 35(3 Suppl 3):14-21. PubMed ID: 9685175
[No Abstract] [Full Text] [Related]
35. Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Brown JR; Kim HT; Li S; Stephans K; Fisher DC; Cutler C; Ho V; Lee SJ; Milford EL; Ritz J; Antin JH; Soiffer RJ; Gribben JG; Alyea EP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1056-64. PubMed ID: 17084369
[TBL] [Abstract][Full Text] [Related]
36. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia.
Rossini MS; de Souza EM; Cintra ML; Pagnano KB; Chiari AC; Lorand-Metze I
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):538-42. PubMed ID: 15324388
[TBL] [Abstract][Full Text] [Related]
38. [Chronic lymphatic leukemia. Peroral cladribine as primary treatment].
Gjedde SB; Juliusson G; Hansen MM
Ugeskr Laeger; 1996 Nov; 158(45):6432-4. PubMed ID: 8992677
[TBL] [Abstract][Full Text] [Related]
39. Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Flinn IW; Neuberg DS; Grever MR; Dewald GW; Bennett JM; Paietta EM; Hussein MA; Appelbaum FR; Larson RA; Moore DF; Tallman MS
J Clin Oncol; 2007 Mar; 25(7):793-8. PubMed ID: 17283364
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD
Br J Haematol; 2007 Nov; 139(3):398-404. PubMed ID: 17910629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]